A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 06, 2018
Source ID
10.1007/s10637-018-0578-9

Entities

People

  • Alba Torres
  • Andrew C Hsieh
  • Brett S. Carver
  • Dana E. Rathkopf
  • Greg Shelkey
  • Howard I. Scher
  • Kalyan Banda
  • Katie Pisano
  • Laura S Graham
  • Tamara L Lotan
  • Tracy Curley
  • Yu Chen

Organizations

  • American Association for Cancer Research
  • American Society of Clinical Oncology
  • Burroughs Wellcome Fund
  • Congressionally Directed Medical Research Programs
  • National Cancer Institute
  • Prostate Cancer Foundation
  • V Foundation for Cancer Research